679 related articles for article (PubMed ID: 20569105)
41. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
42. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
43. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
44. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
[TBL] [Abstract][Full Text] [Related]
45. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
[TBL] [Abstract][Full Text] [Related]
46. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
[TBL] [Abstract][Full Text] [Related]
47. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
48. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
49. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
50. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
[TBL] [Abstract][Full Text] [Related]
51. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
52. Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics.
Ates S; Sevket O; Sudolmus S; Dane B; Ozkal F; Uysal O; Dansuk R
Gynecol Endocrinol; 2013 Oct; 29(10):931-5. PubMed ID: 23998514
[TBL] [Abstract][Full Text] [Related]
53. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia.
Papalou O; Livadas S; Karachalios A; Tolia N; Kokkoris P; Tripolitakis K; Diamanti-Kandarakis E
Hormones (Athens); 2015; 14(1):91-100. PubMed ID: 25553762
[TBL] [Abstract][Full Text] [Related]
54. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
55. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
Macut D; Damjanovic S; Panidis D; Spanos N; Glisic B; Petakov M; Rousso D; Kourtis A; Bjekic J; Milic N
Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
[TBL] [Abstract][Full Text] [Related]
56. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
57. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A
PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195
[TBL] [Abstract][Full Text] [Related]
58. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
Li L; Feng Q; Ye M; He Y; Yao A; Shi K
J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
[TBL] [Abstract][Full Text] [Related]
59. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.
Cengiz H; Ekin M; Dagdeviren H; Yildiz Ş; Kaya C; Kanawati A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408
[TBL] [Abstract][Full Text] [Related]
60. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
